Literature DB >> 22075253

Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.

Sigrid K Brækkan1, Erin M Hald, Ellisiv B Mathiesen, Inger Njølstad, Tom Wilsgaard, Frits R Rosendaal, John-Bjarne Hansen.   

Abstract

OBJECTIVE: To investigate and compare the impact of traditional atherosclerotic risk factors for the risk of arterial and venous thrombosis, taking into account competing risks. METHODS AND
RESULTS: In 1994-1995, 26,185 subjects were screened in the Tromsø study. Information on traditional atherosclerotic risk factors was obtained by physical examination, blood samples, and questionnaires. Subjects were followed to the first incident event of myocardial infarction (MI) or venous thromboembolism (VTE), or December 31, 2005. During a median of 10.8 years of follow-up, there were 1279 cases of incident MI and 341 VTE events. Advancing age and high body mass index were both associated with MI and VTE. Hazard ratio per decade of age was 2.34 (95% CI: 2.25-2.43) for MI and 1.87 (1.74-2.01) for VTE, and 3 kg/m(2) increase in body mass index was associated with 1.16 (1.11-1.21) and 1.20 (1.12-1.29) increased risk of MI and VTE, respectively. Blood pressure, high levels of triglycerides and total cholesterol, low HDL cholesterol, self-reported diabetes, and smoking were all associated with increased risk of MI but not associated with VTE.
CONCLUSIONS: Our findings imply that traditional atherosclerotic risk factors, such as smoking, hypertension, dyslipidemia, and diabetes mellitus are not shared by arterial and venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075253     DOI: 10.1161/ATVBAHA.111.237545

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

1.  AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis.

Authors:  Wanmu Xie; Lin Zhang; Wei Luo; Zhenguo Zhai; Chen Wang; Ying H Shen
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

2.  Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population.

Authors:  Nadia Arshad; Trond Isaksen; John-Bjarne Hansen; Sigrid K Brækkan
Journal:  Eur J Epidemiol       Date:  2017-03-17       Impact factor: 8.082

Review 3.  Is there a Link Between Atherothrombosis and Deep Venous Thrombosis?

Authors:  Maria-Cristina Andrei; Aurel Andercou
Journal:  Maedica (Buchar)       Date:  2014-03

4.  Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Authors:  Bakhtawar K Mahmoodi; Mary Cushman; Inger Anne Næss; Matthew A Allison; Willem J Bos; Sigrid K Brækkan; Suzanne C Cannegieter; Ron T Gansevoort; Philimon N Gona; Jens Hammerstrøm; John-Bjarne Hansen; Susan Heckbert; Anders G Holst; Susan G Lakoski; Pamela L Lutsey; JoAnn E Manson; Lisa W Martin; Kunihiro Matsushita; Karina Meijer; Kim Overvad; Eva Prescott; Marja Puurunen; Jacques E Rossouw; Yingying Sang; Marianne T Severinsen; Jur Ten Berg; Aaron R Folsom; Neil A Zakai
Journal:  Circulation       Date:  2016-11-09       Impact factor: 29.690

Review 5.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Authors:  Laila Staerk; Jason A Sherer; Darae Ko; Emelia J Benjamin; Robert H Helm
Journal:  Circ Res       Date:  2017-04-28       Impact factor: 17.367

Review 6.  Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.

Authors:  Elizabeth J Bell; Aaron R Folsom; Pamela L Lutsey; Elizabeth Selvin; Neil A Zakai; Mary Cushman; Alvaro Alonso
Journal:  Diabetes Res Clin Pract       Date:  2015-11-10       Impact factor: 5.602

7.  Obesity measures and risk of venous thromboembolism and myocardial infarction.

Authors:  Lars D Horvei; Sigrid K Brækkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Eur J Epidemiol       Date:  2014-09-12       Impact factor: 8.082

8.  Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.

Authors:  Marc Blondon; Kerri L Wiggins; Astrid Van Hylckama Vlieg; Barbara McKnight; Bruce M Psaty; Kenneth M Rice; Susan R Heckbert; Nicholas L Smith
Journal:  Br J Haematol       Date:  2013-08-08       Impact factor: 6.998

9.  Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study.

Authors:  Elizabeth J Bell; Elizabeth Selvin; Pamela L Lutsey; Vijay Nambi; Mary Cushman; Aaron R Folsom
Journal:  Vasc Med       Date:  2013-10       Impact factor: 3.239

10.  Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study.

Authors:  Tove Skjelbakken; Jostein Lappegård; Trygve S Ellingsen; Elizabeth Barrett-Connor; Jan Brox; Maja-Lisa Løchen; Inger Njølstad; Tom Wilsgaard; Ellisiv B Mathiesen; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2014-08-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.